| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/04/2003 | WO2002000932A3 Diagnosis of known genetic parameters within the mhc |
| 09/04/2003 | WO2001092299A3 Adenovirus particles with mutagenized fiber proteins |
| 09/04/2003 | WO2001081622A3 Diagnosis of diseases associated with dna repair |
| 09/04/2003 | WO2001076451A3 Diagnosis of diseases associated with metabolism |
| 09/04/2003 | WO2001066595A9 Human fgf-23 gene and gene expression products |
| 09/04/2003 | WO2001057261A9 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 09/04/2003 | WO2000040204A3 Methods for treating cystic fibrosis |
| 09/04/2003 | US20030167539 Genetically modified plants having modulated flower development |
| 09/04/2003 | US20030167537 Genetic engineered polynucleotide; adjusting transcription factor |
| 09/04/2003 | US20030167533 Intein-mediated protein splicing |
| 09/04/2003 | US20030167531 Cytokines; growth hormone; granulocyte colony stimulating factor |
| 09/04/2003 | US20030167526 Comprises introducing anthocyanin polynucleotides into target cells; corn; soybeans |
| 09/04/2003 | US20030167522 Obtained from Bacillus thuringiensis (cry proteins); for activity against corn rootworm pests |
| 09/04/2003 | US20030167521 Genetic engineered insecticide |
| 09/04/2003 | US20030167519 Chimeric gene encoding drosomycin, vector containing it and production of disease-resistant transgenic plants |
| 09/04/2003 | US20030167517 Cry proteins for recombination within plant cells |
| 09/04/2003 | US20030167512 Method of determining the presence of a trait in a plant by transfecting a nucleic acid sequence of a donor plant into a different host plant in a positive orientation |
| 09/04/2003 | US20030167506 Expansin protein and polynucleotides and methods of use |
| 09/04/2003 | US20030167505 Cell cycle nucleic acids, polypeptides and uses thereof |
| 09/04/2003 | US20030167504 Maize Rar1-interactor polynucleotides and methods of use |
| 09/04/2003 | US20030167502 Human monoclonal antibodies to dendritic cells |
| 09/04/2003 | US20030167498 Comprises G-protein gamma subunits (GNG4); transgenic mice; dietetics; drug screening |
| 09/04/2003 | US20030167496 Transgenic non-human mammals carrying human pituitary tumor transforming gene (PTTG) sequences |
| 09/04/2003 | US20030167493 G-protein coupled receptors (GPCRs); transmembrane proteins; for increased pain threshold; analgesics; drug screening |
| 09/04/2003 | US20030167491 Inositol 1,4,5-triphosphate receptors (IP3R); ankyrin-B; for treatment of cardiac hypertrophy, diabetes, pancreas, respiratory system disorders, blood disorders, vision disorders, endocrine inbalance, and/or pain/inflammation |
| 09/04/2003 | US20030167490 Gene expression inhibiton/knockout; serpins; fusion proteins |
| 09/04/2003 | US20030167488 Mice heterozygous for WFS1 gene as mouse models for depression |
| 09/04/2003 | US20030167487 Homologous recombination; stem cells; drug screening; platelets |
| 09/04/2003 | US20030167485 Novel G protein-coupled receptor encoding gene and diagnostic uses therefor |
| 09/04/2003 | US20030167482 Novel semaphorin Z and gene encoding the same |
| 09/04/2003 | US20030167480 Diagnosis, therapy of cancer using antibodies; detcting, calibration binding |
| 09/04/2003 | US20030167479 Diagnosis of vascular system disease; measuring Dna in test sample; calibration |
| 09/04/2003 | US20030167478 Epsin protein detected in injuries; controlling cell differentiation, cell proliferation |
| 09/04/2003 | US20030167477 Fusion proteins incorporating lysozyme |
| 09/04/2003 | US20030167476 Selective target cell activation by expression of a G protein-coupled receptor activated superiorly by synthetic ligand |
| 09/04/2003 | US20030167475 Methods for modulation of cholesterol transport |
| 09/04/2003 | US20030167129 Antiinflammatory agents; detecting binding to cellular library; separation; calibration |
| 09/04/2003 | US20030167015 Animal model of atrial fibrillation and screening and therapeutic methods relating thereto |
| 09/04/2003 | US20030166960 Method of purifying a hydrophobin present in a hydrophobin-containing solution |
| 09/04/2003 | US20030166917 Purification by chromatography, ion exchanging, analyzing |
| 09/04/2003 | US20030166915 Retrovirus from the HIV group and its use |
| 09/04/2003 | US20030166914 Antitumor agents; antiinflammatory agents |
| 09/04/2003 | US20030166913 Novel beta-defensins |
| 09/04/2003 | US20030166912 Novel beta-defensins |
| 09/04/2003 | US20030166911 Hybrid nucleic acids; genetic engineering |
| 09/04/2003 | US20030166910 Bone morphogenic protein |
| 09/04/2003 | US20030166909 EGF motif protein, EGFL6 materials and methods |
| 09/04/2003 | US20030166908 Seafood protein; measuring water absorption of fish bladder |
| 09/04/2003 | US20030166907 Mammalian neuro-growth factor like protein |
| 09/04/2003 | US20030166906 Hybrid polynucleotides; modulate immunology response |
| 09/04/2003 | US20030166904 Human narcolepsy gene |
| 09/04/2003 | US20030166903 Genes associated with vascular disease |
| 09/04/2003 | US20030166901 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166898 Myelin oligodendrocyte glycoprotein-like protein (MOGp) |
| 09/04/2003 | US20030166896 Polynucleotide containing phosphoramidite group |
| 09/04/2003 | US20030166895 Gene expression; genetic engineering; central nervous system disorders; cardiovascular disorders; glandular disorders; psychological disorders |
| 09/04/2003 | US20030166894 Isolated nucleic acids; therapy, diagnosis |
| 09/04/2003 | US20030166893 Measuring, calibrating drug resistance |
| 09/04/2003 | US20030166892 58566, a human anion exchanger family member and uses therefor |
| 09/04/2003 | US20030166891 Novel Bt toxin receptors from lepidopteran insects and methods of use |
| 09/04/2003 | US20030166887 Diagnosis, therapy of bone disorders; modulation cell differentiation |
| 09/04/2003 | US20030166886 Candida albicans proteins associated with virulence and hyphal formation and uses thereof |
| 09/04/2003 | US20030166885 52948, a human ABC transporter family member and uses therefor |
| 09/04/2003 | US20030166884 Nucleotide sequences which code for the rpoB gene |
| 09/04/2003 | US20030166883 Genetic engineering; drug screening |
| 09/04/2003 | US20030166882 Novel polypeptide |
| 09/04/2003 | US20030166881 Variations, modulation in gene expression; transgenic animals; skin disorders |
| 09/04/2003 | US20030166880 57304, a novel human organic cation transporter and uses thereof |
| 09/04/2003 | US20030166877 Reducing the immunogenicity of fusion proteins |
| 09/04/2003 | US20030166876 Method of treating cancer including administering a human chimeric antibody specific for the ganglioside GD3 |
| 09/04/2003 | US20030166875 Fibroblast growth factor homologous factor-2 and methods of use |
| 09/04/2003 | US20030166873 Endothelial growth factor; measuring binding to monoclonal antibodies; calibration |
| 09/04/2003 | US20030166869 Chromatography separation using apatite |
| 09/04/2003 | US20030166867 Fibrin nanoparticles and uses thereof |
| 09/04/2003 | US20030166866 Distillation; separation |
| 09/04/2003 | US20030166865 Loop protein immobilized with polyethylene glycol |
| 09/04/2003 | US20030166864 Controlling immunology; antiinflammatory agents |
| 09/04/2003 | US20030166863 Macrophage migration inhibitory factor-3 |
| 09/04/2003 | US20030166862 Purified mammalian CTLA-8 antigens and related reagents |
| 09/04/2003 | US20030166861 Human blue-light photoreceptor hCRY2 |
| 09/04/2003 | US20030166860 Peptide or protein containing a C '-D loop of the CD28 receptor family |
| 09/04/2003 | US20030166859 Controlling cell proliferation, cell differentiation; anticancer agents |
| 09/04/2003 | US20030166858 Isolated nucleic acids; antitumor agents; wound healing agents |
| 09/04/2003 | US20030166857 Genes for receptor tyrosine kinases and their cognate ligands, their insertion into genetic engineered DNA vectors; useful in the diagnosis and treatment of neoplastic diseases |
| 09/04/2003 | US20030166856 A set of open reading frames encoded with the template as the plus strand of the proviral DNA, and located in the region of HIV-1 long terminal repeat, and the genes encode a set of antisense proteins |
| 09/04/2003 | US20030166855 Lipoxygenase polynucleotides and methods of use |
| 09/04/2003 | US20030166854 Allelic variant of human STAT3 |
| 09/04/2003 | US20030166853 Mucin peptide with immunoenhancing properties |
| 09/04/2003 | US20030166852 Proteinase inhibitor ZSERP9 |
| 09/04/2003 | US20030166850 Containing an isolated human evectin polypeptide binding domain |
| 09/04/2003 | US20030166849 A peptide of at least 5 amino acids containing a unique portion of a semaphorin, and such peptide has a semaphorin binding specificity |
| 09/04/2003 | US20030166848 Polypeptides having specific amino acid sequence lacking its associated signal peptide; a chimeric polypeptide fused to a heterologous polypeptide which is an epitope tag or an Fc region of an immunoglobulin |
| 09/04/2003 | US20030166847 Novel human leptin receptor gene-related protein |
| 09/04/2003 | US20030166846 Self-aligning peptides modeled on human elastin and other fibrous proteins |
| 09/04/2003 | US20030166845 Novel proteins and nucleic acids encoding same |
| 09/04/2003 | US20030166844 Immunologenic polypeptides; therapy for Streptococcus infections |
| 09/04/2003 | US20030166842 Mammalian pro-alpha3(V) collagen chain genes |
| 09/04/2003 | US20030166838 A biologically active peptide at least 85% identical to a peptide: (a) X01ValSerGluX02GlnLeuX03HisX04X05GlyLysX06; (b) fragments containing amino acids 1-9, 1-10, 1-11, 1-12,(c) a salt or (d) N- or C- derivatives |
| 09/04/2003 | US20030166837 Isolated molecules which complex with HLA-Cw*16 molecules, and uses thereof |
| 09/04/2003 | US20030166836 A polypeptide produced by the parathyroid glands using such analogues alone or in combination with a bisphosphonate or calcitonin to treat osteoporosis |